Literature DB >> 17520179

The lack of expression of the peripheral benzodiazepine receptor characterises microglial response in anaplastic astrocytomas.

Shigetoshi Takaya1, Kazuo Hashikawa, Federico E Turkheimer, Nicholas Mottram, Manuel Deprez, Koichi Ishizu, Hidekazu Kawashima, Haruhiko Akiyama, Hidenao Fukuyama, Richard B Banati, Federico Roncaroli.   

Abstract

The peripheral benzodiazepine receptor (PBR) is a 18 kDa molecule mainly involved in cholesterol transport through the mitochondrial membrane. In microglia, PBR is expressed from the earliest stages of activation and appears to exert a pro-inflammatory function. This molecule is commonly up-regulated in inflammatory, degenerative, infective and ischaemic lesions of the central nervous system but it has never been reported in glioma-infiltrating microglia. We examined two anaplastic astrocytomas showing minimal contrast-enhancement and therefore little damage of the blood brain barrier to minimise the presence of blood borne macrophages within tumour tissue. The two lesions were studied in vivo using positron emission tomography (PET) with the specific PBR ligand [(11)C](R)-PK11195 and the corresponding tumour tissue was investigated with an anti-PBR antibody. Glioma-infiltrating microglia were characterised for molecules involved in antigen presentation and cytotoxic activity. As comparison, PBR was investigated in three brains with multiple sclerosis (MS) and three with Parkinson's disease (PD). The expression profile of four anaplastic astrocytomas was also exploited and results were compared to the profile of eleven samples of normal temporal lobe and nine cases of PD. PET studies showed that [(11)C](R)-PK11195 binding was markedly lower in tumours than in the contralateral grey matter. Pathological investigation revealed that glioma-infiltrating microglia failed to express PBR and cytotoxic molecules although some cells still expressed antigen presenting molecules. PBR and cytotoxic molecules were highly represented in MS and PD. Evaluation of microarray datasets confirmed these differences. Our results demonstrated PBR suppression in glioma-infiltrating microglia and suggested that PBR may have a relevant role in modulating the anti-tumour inflammatory response in astrocytic tumours.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17520179     DOI: 10.1007/s11060-007-9396-1

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  49 in total

1.  Distribution and characterization of microglia/macrophages in human brain tumors.

Authors:  W Roggendorf; S Strupp; W Paulus
Journal:  Acta Neuropathol       Date:  1996-09       Impact factor: 17.088

2.  Cellular and subcellular localization of peripheral benzodiazepine receptors after trimethyltin neurotoxicity.

Authors:  A C Kuhlmann; T R Guilarte
Journal:  J Neurochem       Date:  2000-04       Impact factor: 5.372

3.  Assessment of the peripheral benzodiazepine receptors in human gliomas by two methods.

Authors:  N Miyazawa; E Hamel; M Diksic
Journal:  J Neurooncol       Date:  1998-05       Impact factor: 4.130

4.  Imaging of human brain lesions with an omega 3 site radioligand.

Authors:  J Benavides; P Cornu; T Dennis; A Dubois; J J Hauw; E T MacKenzie; V Sazdovitch; B Scatton
Journal:  Ann Neurol       Date:  1988-12       Impact factor: 10.422

Review 5.  The WHO classification of tumors of the nervous system.

Authors:  Paul Kleihues; David N Louis; Bernd W Scheithauer; Lucy B Rorke; Guido Reifenberger; Peter C Burger; Webster K Cavenee
Journal:  J Neuropathol Exp Neurol       Date:  2002-03       Impact factor: 3.685

6.  Subcellular localization of peripheral benzodiazepine receptors on human leukocytes.

Authors:  D Cahard; X Canat; P Carayon; C Roque; P Casellas; G Le Fur
Journal:  Lab Invest       Date:  1994-01       Impact factor: 5.662

7.  Involvement of benzodiazepine receptors in neuroinflammatory and neurodegenerative diseases: evidence from activated microglial cells in vitro.

Authors:  H Wilms; J Claasen; C Röhl; J Sievers; G Deuschl; R Lucius
Journal:  Neurobiol Dis       Date:  2003-12       Impact factor: 5.996

Review 8.  Visualising microglial activation in vivo.

Authors:  Richard B Banati
Journal:  Glia       Date:  2002-11       Impact factor: 8.073

9.  Microglia in culture: what genes do they express?

Authors:  D C Duke; L B Moran; F E Turkheimer; R Banati; M B Graeber
Journal:  Dev Neurosci       Date:  2004 Jan-Feb       Impact factor: 2.984

10.  Chromosomal patterns of gene expression from microarray data: methodology, validation and clinical relevance in gliomas.

Authors:  Federico E Turkheimer; Federico Roncaroli; Benoit Hennuy; Christian Herens; Minh Nguyen; Didier Martin; Annick Evrard; Vincent Bours; Jacques Boniver; Manuel Deprez
Journal:  BMC Bioinformatics       Date:  2006-12-01       Impact factor: 3.169

View more
  14 in total

1.  The expression of translocator protein in human thyroid cancer and its role in the response of thyroid cancer cells to oxidative stress.

Authors:  Joanna Klubo-Gwiezdzinska; Kirk Jensen; Andrew Bauer; Aneeta Patel; John Costello; Kenneth D Burman; Leonard Wartofsky; Matthew J Hardwick; Vasyl V Vasko
Journal:  J Endocrinol       Date:  2012-05-29       Impact factor: 4.286

2.  TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative 18F-GE-180 PET study.

Authors:  M Unterrainer; D F Fleischmann; F Vettermann; V Ruf; L Kaiser; D Nelwan; S Lindner; M Brendel; V Wenter; S Stöcklein; J Herms; V M Milenkovic; R Rupprecht; J C Tonn; C Belka; P Bartenstein; M Niyazi; N L Albert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-09-05       Impact factor: 9.236

3.  TSPO PET for glioma imaging using the novel ligand 18F-GE-180: first results in patients with glioblastoma.

Authors:  Nathalie L Albert; M Unterrainer; D F Fleischmann; S Lindner; F Vettermann; A Brunegraf; L Vomacka; M Brendel; V Wenter; C Wetzel; R Rupprecht; J-C Tonn; C Belka; P Bartenstein; M Niyazi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-08-19       Impact factor: 9.236

4.  An In Vivo 11C-(R)-PK11195 PET and In Vitro Pathology Study of Microglia Activation in Creutzfeldt-Jakob Disease.

Authors:  Leonardo Iaccarino; Rosa Maria Moresco; Luca Presotto; Orso Bugiani; Sandro Iannaccone; Giorgio Giaccone; Fabrizio Tagliavini; Daniela Perani
Journal:  Mol Neurobiol       Date:  2017-04-28       Impact factor: 5.590

5.  Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain.

Authors:  M Cosenza-Nashat; M-L Zhao; H-S Suh; J Morgan; R Natividad; S Morgello; S C Lee
Journal:  Neuropathol Appl Neurobiol       Date:  2008-12-11       Impact factor: 8.090

6.  Comparison of 18F-GE-180 and dynamic 18F-FET PET in high grade glioma: a double-tracer pilot study.

Authors:  Marcus Unterrainer; D F Fleischmann; C Diekmann; L Vomacka; S Lindner; F Vettermann; M Brendel; V Wenter; B Ertl-Wagner; J Herms; C Wetzel; R Rupprecht; J C Tonn; C Belka; P Bartenstein; M Niyazi; Nathalie L Albert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-09-22       Impact factor: 9.236

Review 7.  Noninvasive molecular imaging of neuroinflammation.

Authors:  Andreas H Jacobs; Bertrand Tavitian
Journal:  J Cereb Blood Flow Metab       Date:  2012-05-02       Impact factor: 6.200

8.  [¹¹C]-(R)PK11195 tracer kinetics in the brain of glioma patients and a comparison of two referencing approaches.

Authors:  Zhangjie Su; Karl Herholz; Alexander Gerhard; Federico Roncaroli; Daniel Du Plessis; Alan Jackson; Federico Turkheimer; Rainer Hinz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-29       Impact factor: 9.236

Review 9.  TSPO expression in brain tumours: is TSPO a target for brain tumour imaging?

Authors:  Federico Roncaroli; Zhangjie Su; Karl Herholz; Alexander Gerhard; Federico E Turkheimer
Journal:  Clin Transl Imaging       Date:  2016-03-22

Review 10.  The methodology of TSPO imaging with positron emission tomography.

Authors:  Federico E Turkheimer; Gaia Rizzo; Peter S Bloomfield; Oliver Howes; Paolo Zanotti-Fregonara; Alessandra Bertoldo; Mattia Veronese
Journal:  Biochem Soc Trans       Date:  2015-08-03       Impact factor: 5.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.